Diabetes and Metabolism Journal

Korean Diabetes Association (대한당뇨병학회)
권호 표지
DOI QR코드

DOI QR Code

The Association between Serum GGT Concentration and Diabetic Peripheral Polyneuropathy in Type 2 Diabetic Patients

Cho, Ho-Chan

  • Published : 20100000
⟨ Previous Next ⟩

Abstract

Background: Diabetic peripheral polyneuropathy (DPP) is one of the common complications of diabetes mellitus (DM) and can lead to foot ulcers or amputation. The pathophysiology of DPP includes several factors such as metabolic, vascular, autoimmune, oxidative stress and neurohormonal growth-factor deficiency and recent studies have suggested the use of serum gammaglutamyl transferase (GGT) as an early marker of oxidative stress. Therefore, we investigated whether serum GGT may be useful in predicting DPP. Methods: We assessed 90 patients with type 2 DM who were evaluated for the presence of DPP using clnical neurologic examinations including nerve conduction velocity studies. We evaluated the association between serum GGT and the presence of DPP. Results: The prevalence of DPP was 40% (36 cases) according to clinical neurological examinations. The serum GGT concentration was significantly elevated in type 2 diabetic patients with DPP compared to patients without DPP (P < 0.01). There were other factors significantly associated with DPP including smoking (P = 0.019), retinopathy (P = 0.014), blood pressure (P < 0.05), aspartate aminotransferase (P = 0.022), C-reactive protein (P = 0.036) and urine microalbumin/creatinine ratio (P = 0.004). Serum GGT was independently related with DPP according to multiple logistic analysis (P < 0.01). Conclusion: This study shows that increased levels of serum GGT may have important clinical implications in the presence of DPP in patients with type 2 diabetes.

Keywords

References

  1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53 https://doi.org/10.2337/diacare.27.5.1047
  2. Carrington AL, Shaw JE, Van Schie CH, Abbott CA, Vileikyte L, Boulton AJ. Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care 2002;25:2010-5 https://doi.org/10.2337/diacare.25.11.2010
  3. Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia 2000;43:957-73 https://doi.org/10.1007/s001250051477
  4. Kim BW, Kim DH, Kim JG. Comparisons between several neurologic tests of large myelinated nerves in type 2 diabetic patients with peripheral polyneuropathy. J Korean Diabetes Assoc 1999;23:562-74
  5. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17:1281-9 https://doi.org/10.2337/diacare.17.11.1281
  6. van Deursen RW, Sanchez MM, Derr JA, Becker MB, Ulbrecht JS, Cavanagh PR. Vibration perception threshold testing in patients with diabetic neuropathy: ceiling effects and reliability. Diabet Med 2001;18:469-75 https://doi.org/10.1046/j.1464-5491.2001.00503.x
  7. Mueller MJ. Identifying patients with diabetes mellitus who are at risk for lower-extremity complications: use of Semmes-Weinstein monofilaments. Phys Ther 1996;76:68-71 https://doi.org/10.1093/ptj/76.1.68
  8. Ferreira MC, Rodrigues L, Fels K. New method for evaluation of cutaneous sensibility in diabetic feet: preliminary report. Rev Hosp Clin Fac Med Sao Paulo 2004;59:286-90 https://doi.org/10.1590/S0041-87812004000500011
  9. Hopps E, Noto D, Caimi G, Averna MR. A novel component of the metabolic syndrome: the oxidative stress. Nutr Metab Cardiovasc Dis 2010;20:72-7 https://doi.org/10.1016/j.numecd.2009.06.002
  10. Lim JS, Yang JH, Chun BY, Kam S, Jacobs DR Jr, Lee DH. Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress? Free Radic Biol Med 2004;37:1018-23 https://doi.org/10.1016/j.freeradbiomed.2004.06.032
  11. Jung YS, Lee KY, Lee SK, Kim HK, Park HY, Kang MH. Peripheral polyneruopathy and hypoinsulinemia in patients with type 2 diabetes. J Korean Diabetes Assoc 2000;24:256-66
  12. Herder C, Lankisch M, Ziegler D, Rathmann W, Koenig W, Illig T, Doring A, Thorand B, Holle R, Giani G, Martin S, Meisinger C. Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany). Diabetes Care 2009;32:680-2 https://doi.org/10.2337/dc08-2011
  13. Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005;28:164-76 https://doi.org/10.2337/diacare.28.1.164
  14. Cabezas-Cerrato J. The prevalence of clinical diabetic polyneuropathy in Spain: a study in primary care and hospital clinic groups. Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS). Diabetologia 1998;41:1263-9 https://doi.org/10.1007/s001250051063
  15. Boulton AJ, Malik RA, Arezzo JC, Sosenko JM. Diabetic somatic neuropathies. Diabetes Care 2004;27:1458-86 https://doi.org/10.2337/diacare.27.6.1458
  16. Figueroa-Romero C, Sadidi M, Feldman EL. Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord 2008;9:301-14 https://doi.org/10.1007/s11154-008-9104-2
  17. Edwards JL, Vincent AM, Cheng HT, Feldman EL. Diabetic neuropathy: mechanisms to management. Pharmacol Ther 2008;120:1-34 https://doi.org/10.1016/j.pharmthera.2008.05.005
  18. Zotova EV, Chistiakov DA, Savost’ianov KV, Bursa TR, Galeev IV, Strokov IA, Nosikov VV. Association of the SOD2 Ala(-9) Val and SOD3 Arg213Gly polymorphisms with diabetic polyneuropathy in patients with diabetes mellitus type 1. Mol Biol (Mosk) 2003;37:404-8 https://doi.org/10.1023/A:1024287327107
  19. Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, Munzel U, Yakhno N, Raz I, Novosadova M, Maus J, Samigullin R. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006;29:2365-70 https://doi.org/10.2337/dc06-1216
  20. Cameron NE, Cotter MA, Horrobin DH, Tritschler HJ. Effects of alpha-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids. Diabetologia 1998;41:390-9 https://doi.org/10.1007/s001250050921
  21. Lee DH, Gross MD, Jacobs DR Jr. Association of serum carotenoids and tocopherols with gamma-glutamyltransferase: the Cardiovascular Risk Development in Young Adults (CARDIA) Study. Clin Chem 2004;50:582-8 https://doi.org/10.1373/clinchem.2003.028852
  22. Drozdz R, Parmentier C, Hachad H, Leroy P, Siest G, Wellman M. gamma-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med 1998;25:786-92 https://doi.org/10.1016/S0891-5849(98)00127-0
  23. Takigawa T, Hibino Y, Kimura S, Yamauchi H, Wang B, Wang D, Ogino K. Association between serum gamma-glutamyltransferase and oxidative stress related factors. Hepatogastroenterology 2008;55:50-3
  24. Bonnefont-Rousselot D, Beaudeux JL, Therond P, Peynet J, Legrand A, Delattre J. Diabetes mellitus, oxidative stress and advanced glycation endproducts. Ann Pharm Fr 2004;62:147-57 https://doi.org/10.1016/S0003-4509(04)94297-6
  25. Aikawa M, Sugiyama S, Hill CC, Voglic SJ, Rabkin E, Fukumoto Y, Schoen FJ, Witztum JL, Libby P. Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma. Circulation 2002;106:1390-6 https://doi.org/10.1161/01.CIR.0000028465.52694.9B
  26. Demircan N, Gurel A, Armutcu F, Unalacak M, Aktunc E, Atmaca H. The evaluation of serum cystatin C, malondialdehyde, and total antioxidant status in patients with metabolic syndrome. Med Sci Monit 2008;14:CR97-101
  27. Lim JS, Kim YJ, Chun BY, Yang JH, Lee DH, Kam S. The association between serum GGT level within normal range and risk factors of cardiovascular diseases. J Prev Med Public Health 2005;38:101-6
  28. Koh JH, Lee MY, Nam SM, Sung JK, Jung PM, Noh JK, Shin JY, Shin YG, Chung CH. Relationship between menopausal status and metabolic syndrome components in Korean women. Korean Diabetes J 2008;32:243-51 https://doi.org/10.4093/kdj.2008.32.3.243
  29. Elliott J, Tesfaye S, Chaturvedi N, Gandhi RA, Stevens LK, Emery C, Fuller JH. Large-fiber dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors. Diabetes Care 2009;32:1896-900 https://doi.org/10.2337/dc09-0554
  30. Jurado J, Ybarra J, Romeo JH, Pou JM. Clinical screening and diagnosis of diabetic polyneuropathy: the North Catalonia Diabetes Study. Eur J Clin Invest 2009;39:183-9 https://doi.org/10.1111/j.1365-2362.2008.02074.x
  31. Jin HY, Jeung SJ, Kim CH, Park JH, Baek HS, Park TS. Erythropoietin levels according to the presence of peripheral neuropathy in diabetic patients with anemia. J Korean Diabetes Assoc 2007;31:151-6 https://doi.org/10.4093/jkda.2007.31.2.151
  32. Jeong IK, Park KS, Moon MK, Kim JH, Shin CS, Kim SY, Lee HK. The association of aldose reductase gene polymorphisms with neuropathy in patients with type 2 diabetes. J Korean Diabetes Assoc 2007;31:274-83 https://doi.org/10.4093/jkda.2007.31.3.274
  33. Ha SW, Lee HJ, Han JH, Jung SW, Nam JH, Sin BH, Koo SM, Kim JG, Kwon S, Kim BW. Relationship between peripheral neuropathy and cardiovascular autonomic neuropathy in noninsulin dependent diabetics. J Korean Diabetes Assoc 1997;21:476-83

Cited by

  1. Serum γ‐glutamyltransferase and associated damage among a She Chinese population vol.28, pp.8, 2010, https://doi.org/10.1111/j.1464-5491.2011.03270.x
  2. Antioxidant Effects of Fermented Red Ginseng Extracts in Streptozotocin-Induced Diabetic Rats vol.35, pp.2, 2010, https://doi.org/10.5142/jgr.2011.35.2.129
  3. Angiotensin-converting enzyme gene single polymorphism as a genetic biomarker of diabetic peripheral neuropathy: longitudinal prospective study vol.26, pp.2, 2010, https://doi.org/10.1016/j.jdiacomp.2012.02.011
  4. The Effect of Cigarette Smoking on Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis vol.30, pp.8, 2015, https://doi.org/10.1007/s11606-015-3354-y
  5. Dissociable Contributions of Precuneus and Cerebellum to Subjective and Objective Neuropathy in HIV vol.14, pp.3, 2010, https://doi.org/10.1007/s11481-019-09837-2
  6. Early Biomarkers of Neurodegenerative and Neurovascular Disorders in Diabetes vol.9, pp.9, 2010, https://doi.org/10.3390/jcm9092807